Know Cancer

or
forgot password

Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing ERCP.


N/A
18 Years
75 Years
Not Enrolling
Both
Primary Sclerosing Cholangitis

Thank you

Trial Information

Cholangioscopy Using Narrow Band Imaging (NBI) in Patients With Primary Sclerosing Cholangitis (PSC) Undergoing ERCP.


Inclusion Criteria:



- Patients with PSC presenting for ERCP where tissue sampling is indicated

- Adults age 18 to 75 years old

- Able to give informed written consent

- Either male or female

Exclusion Criteria:

- PSC with acute cholangitis

- Patients with acute or chronic, debilitating cardiopulmonary disease who are unable
to safely undergo prolonged conscious sedation

- Patients with a prior history of liver transplant

- Prisoners

- Unable or unwilling to give informed consents

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Cholangioscopy with NBI will enhance the ability to identify sites of potential dysplasia or malignancy in patients with PSC and will be more sensitive in identifying dysplasia than ERCP with biliary brushing and fluoroscopy-guided forceps biopsy.

Outcome Time Frame:

One year

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

08-006221

NCT ID:

NCT00951327

Start Date:

November 2008

Completion Date:

August 2010

Related Keywords:

  • Primary Sclerosing Cholangitis
  • Primary sclerosing cholangitis
  • Cholangitis
  • Cholangitis, Sclerosing

Name

Location

Mayo Clinic RochesterRochester, Minnesota  55905